World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
18866
World Ranking
18531
National Ranking
73

Overview

Jae Weon Kim is affiliated with Seoul National University in South Korea and has a research focus primarily within the field of Medicine. Their work spans multiple subfields, including Reproductive Medicine, Obstetrics and Gynecology, Oncology, Surgery, and Epidemiology.

Their research concentrates on specific topics such as ovarian cancer diagnosis and treatment, endometrial and cervical cancer treatments, PARP inhibition in cancer therapy, cervical cancer and HPV research, intraperitoneal and appendiceal malignancies, BRCA gene mutations in cancer, and endometriosis research and treatment.

Frequent coauthors contributing significantly alongside Jae Weon Kim include Se Ik Kim, Hee Seung Kim, Maria Lee, Chel Hun Choi, and Hyun Hoon Chung.

Jae Weon Kim has published considerable work across key academic venues, with frequent publications found in:

  • Gynecologic Oncology
  • Journal of Gynecologic Oncology
  • International Journal of Gynecological Cancer
  • Journal of Clinical Oncology
  • E-Posters

Notable recent papers authored or co-authored by Jae Weon Kim include:

  • Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer, 2024, New England Journal of Medicine
  • Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial, 2020, Journal of Clinical Oncology
  • Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20., 2020, Journal of Clinical Oncology
  • Is coronavirus disease (COVID-19) seasonal? A critical analysis of empirical and epidemiological studies at global and local scales, 2021, Environmental Research
  • Endometrial carcinosarcoma, 2022, International Journal of Gynecological Cancer

Best Publications

  • Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

    Eric Pujade-Lauraine;Jonathan A Ledermann;Frédéric Selle;Val Gebski

  • Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

    Andreas Du Bois;Anne Floquet;Jae Weon Kim;Jae Weon Kim;Joern Rau

  • Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer

    Marcus E. Randall;Virginia Filiaci;D. Scott McMeekin;Vivian Von Gruenigen

  • Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

    Robert L. Coleman;Nick M. Spirtos;Danielle Enserro;Thomas J. Herzog

  • Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.

    Richard T. Penson;Ricardo Villalobos Valencia;David Cibula;Nicoletta Colombo

  • Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).

    Jeong-Yeol Park;Dae-Yeon Kim;Jong-Hyeok Kim;Yong-Man Kim

  • Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20.

    A DuBois;I Vergote;G Ferron;A Reuss

  • Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

    Andrew R. Clamp;Elizabeth C. James;Iain A. McNeish;Andrew Dean

  • Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.

    H.S. Kim;J.E. Sardi;N. Katsumata;H.S. Ryu

  • TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies

    Stefanie J. Klug;Meike Ressing;Jochem Koenig;Martin C. Abba

  • Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.

    Se Ik Kim;Jae Hyun Cho;Aeran Seol;Young Im Kim

  • Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.

    Hyun Hoon Chung;Hoenil Jo;Won Jun Kang;Jae Weon Kim

  • Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.

    Jubilee Brown;Michael Friedlander;Floor J. Backes;Philipp Harter

  • Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

    Dominique Berton-Rigaud;Mojgan Devouassoux-Shisheboran;Jonathan A. Ledermann;Mario M. Leitao

  • Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis in Patients with Epithelial Ovarian Cancer

    Hyun Hoon Chung;Hyun Woo Kwon;Keon Wook Kang;Noh-Hyun Park

  • Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.

    Hyun Hoon Chung;Jae Weon Kim;Kyung Hee Han;Jae Seon Eo

  • Preoperative Identification of a Low-Risk Group for Lymph Node Metastasis in Endometrial Cancer: A Korean Gynecologic Oncology Group Study

    Sokbom Kang;Woo Dae Kang;Hyun Hoon Chung;Dae Hoon Jeong

  • Current status of gynecological cancer in China

    Kidong Kim;Rongyu Zang;Seok Cheol Choi;Sang Young Ryu

  • Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup.

    Giorgia Mangili;Domenica Lorusso;Jubilee Brown;Jacobus Pfisterer

  • Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings.

    Hyun Hoon Chung;Won Jun Kang;Jae Weon Kim;Noh-Hyun Park

Frequent Co-Authors

Yong Sang Song
Yong Sang Song Seoul National University
Michael Friedlander
Michael Friedlander University of New South Wales
Nicoletta Colombo
Nicoletta Colombo University of Milano-Bicocca
Young Tae Kim
Young Tae Kim Seoul National University Hospital
Jonathan A. Ledermann
Jonathan A. Ledermann University College London
Daehee Kang
Daehee Kang Seoul National University
Keun-Young Yoo
Keun-Young Yoo Seoul National University
Giovanni Scambia
Giovanni Scambia Catholic University of the Sacred Heart
Sandro Pignata
Sandro Pignata National Cancer Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can open the door to many healthcare careers beyond the traditional MD route. If you're interested in the business side of medicine, medical billing and coding schools online with financial aid offer flexible, affordable training for in-demand administrative roles.

For those drawn to patient care but seeking a faster or alternative entry point, consider becoming a Licensed Practical Nurse (LPN). There are excellent lpn school without teas test programs, letting you skip common entrance exams and get started sooner.

If you already work in healthcare and want to advance, pursue an accelerated healthcare administration degree online. These programs help you quickly move into leadership and management positions.

Nurses with an associate degree can also progress to advanced clinical roles through specialized asn to fnp programs, bridging the gap from RN to Family Nurse Practitioner.

Each of these paths offers unique opportunities for career growth and lets you make a difference in healthcare—without taking the traditional medical school route.

Best Scientists Citing Jae Weon Kim

Trending Scientists